Filing Details
- Accession Number:
- 0001209191-13-014711
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-06 19:46:36
- Reporting Period:
- 2013-03-04
- Filing Date:
- 2013-03-06
- Accepted Time:
- 2013-03-06 19:46:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1423084 | J. Thomas Schall | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-03-04 | 3,064 | $14.00 | 2,213,103 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-05 | 400 | $14.05 | 2,212,703 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-05 | 318 | $14.03 | 2,212,385 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-05 | 500 | $14.03 | 2,211,885 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-05 | 105 | $14.25 | 2,211,780 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-06 | 1,154 | $14.00 | 2,210,626 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $14.00 to $14.09 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $14.00 to $14.04 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $14.00 to $14.0950 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
